Dirk Kemming
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Genetics top 5%
- Glioma Diagnosis and Treatment
Papers in
-
- Cancer, Hypoxia, and Metabolism 3
- Oncology 8
- Cancer Cells and Metastasis 6
- Co-authors
- Manfred WestphalKatrin LamszusHauke S. GüntherHeidi PhillipsSamir KharbandaRobert SorianoZora ModrušanA.E. Greijer
- Journals
- Journal of Clinical Oncology (3 papers)Clinical Cancer Research (1 paper)British Journal of Cancer (1 paper)Molecular Diagnosis & Therapy (1 paper)BMC Cancer (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Dirk Kemming
21 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 89
- Cancer Research 504
- Genetics 312
- Oncology 423
- Developmental Neuroscience 46
- Molecular Biology 683
Countries citing papers authored by Dirk Kemming
This map shows the geographic impact of Dirk Kemming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Kemming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Kemming more than expected).
Fields of papers citing papers by Dirk Kemming
This network shows the impact of papers produced by Dirk Kemming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Kemming. The network helps show where Dirk Kemming may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Kemming, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 18 | |
| 2 | 2014 | 32 | |
| 3 | 2014 | 22 | |
| 4 | 2013 | 1 | |
| 5 | 2012 | 79 | |
| 6 | 2011 | 98 | |
| 7 | 2011 | 26 | |
| 8 | 2009 | 33 | |
| 9 | 2008 | 69 | |
| 10 | 2007 | 325 | |
| 11 | 2007 | 0 | |
| 12 | 2006 | 8 | |
| 13 | [Expression of early placenta insulin-like growth factor (EPIL) in breast cancer cells provides an autocrine loop with enhancement of predominantly HER-2-related invasivity]. | 2005 | 2 |
| 14 | 2005 | 4 | |
| 15 | 2005 | 20 | |
| 16 | 2005 | 369 | |
| 17 | 2005 | 16 | |
| 18 | 2005 | 3 | |
| 19 | 2004 | 48 | |
| 20 | Early placenta insulin-like growth factor (pro-EPIL) is overexpressed and secreted by c-erbB-2-positive cells with high invasion potential. | 2002 | 20 |
About Dirk Kemming
Dirk Kemming is a scholar working on Cancer Research, Oncology, Molecular Biology, Developmental Neuroscience and Genetics, having authored 22 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (6 papers), RNA modifications and cancer (4 papers), Gene expression and cancer classification (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer-related gene regulation (3 papers), Fibroblast Growth Factor Research (2 papers), Glioma Diagnosis and Treatment (2 papers) and Molecular Biology Techniques and Applications (2 papers). The work is most often cited by research in Cancer Research (504 citations), Genetics (312 citations), Oncology (423 citations), Developmental Neuroscience (46 citations) and Molecular Biology (683 citations). Dirk Kemming has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Manfred Westphal, Katrin Lamszus, Hauke S. Günther, Heidi Phillips, Samir Kharbanda, Robert Soriano, Zora Modrušan, A.E. Greijer, Petra van der Groep and Анна Шварц. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, British Journal of Cancer, Molecular Diagnosis & Therapy and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.